Taken together, these results suggest that formosanin C may be an effective ferroptosis inducer in CRC, and p53 and oncogenic KRAS can separately enhance the vulnerability of CRC cells to formosanin C-induced ferroptosis. The gene discussed is TP53; the disease is colorectal carcinoma.